文献速递关节外科

清创联合局部抗生素治疗全关节置换术后3个月内假体周围感染

Outcome of Irrigation and Debridement With Topical Antibiotics Delivery for the Management of Periprosthetic Joint Infection Occurring Within 3 Months Since the Primary Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-12-01

本研究回顾性分析73例全关节置换术后3个月内发生假体周围感染、接受清创保留假体联合模块组件更换及局部抗生素方案的患者,平均随访63.79个月,总体成功率为87.67%。结果表明该方案是治疗早期假体周围感染可行且安全的选择。

要点

  • DAIR联合模块组件更换及局部抗生素方案治疗术后3个月内PJI,总体成功率为87.67%。
  • 术后接受局部抗生素输注者成功率为88.57%,未接受者为86.84%。
  • 失败定义为需再次手术、持续窦道/引流/剧痛、需抑制性抗生素、同病原复发或再感染等。

核心结论

  • 清创保留假体联合模块组件更换及局部抗生素方案是治疗全关节置换术后3个月内假体周围感染的可行且安全选择。

研究设计与样本

  • 回顾性分析2011年1月至2018年5月接受清创联合模块组件更换及局部抗生素方案的患者。

主要发现

  • 共纳入73例患者,平均年龄63.30±10.97岁,男43例、女30例,膝关节41例、髋关节32例,30例有窦道。
  • 平均随访63.79±18.57个月,共9例失败,总体成功率为87.67%。
  • 术后接受局部抗生素输注者成功率为88.57%,未接受者为86.84%。

关键数值与推荐

  • 失败定义为清创后因感染需额外手术、持续窦道/引流或过度关节痛、因感染需抑制性抗生素治疗、同病原感染复发、不同微生物再感染及感染相关死亡。
  • 局部抗生素输注用于多重耐药菌、真菌、混合感染及培养阴性感染者。

临床怎么用

  • 对于全关节置换术后3个月内发生的假体周围感染,可考虑采用清创联合模块组件更换及局部抗生素方案。

局限性

  • 本研究为回顾性研究,证据等级为Level 4治疗性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Irrigation and debridement with modular component exchange is appealing for surgeons to treat early-stage periprosthetic joint infection (PJI). However, the indication, perioperative protocol, and success rate remain controversial. This study is the first one to present results of debridement, antibiotics, and implant retention (DAIR) with integrated MIT (modular component exchange, povidone-iodine and topical antibiotics delivery) protocol for treating PJI occurring within 3 months since the primary total joint arthroplasty. METHODS: We retrospectively analyzed patients who received DAIR with MIT protocol in our department between January 2011 and May 2018. Topical antibiotics were delivered in all cases. Topical antibiotics infusion was applied for those infected with multidrug-resistant bacteria, fungus, polymicrobial infection, and culture negative one. Failure was defined as additional surgical intervention for infection after DAIR; persistent sinus tract, drainage or excessive joint pain; need for suppressive antibiotics therapy due to the infection; infection relapse with the same pathogen; reinfection with different microorganism; and infection-related death. RESULTS: A total of 73 patients with a mean age of 63.30 ± 10.97 years were included in this study, including 43 men and 30 women. There are 41 knees and 32 hips. Thirty patients had sinus tract. With a mean follow-up of 63.79 ± 18.57 months, there were 9 failures in total with an overall success rate of 87.67%. The success rate was 88.57% and 86.84% for those receiving topical antibiotics infusion postoperatively and those without. CONCLUSIONS: DAIR with a standard MIT protocol is a viable and safe option for PJI occurring within 3 months since the primary total joint arthroplasty. LEVEL OF EVIDENCE: Level 4, therapeutic study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Mu W, Xu B, Guo W, et al. Outcome of Irrigation and Debridement With Topical Antibiotics Delivery for the Management of Periprosthetic Joint Infection Occurring Within 3 Months Since the Primary Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 33358609. doi:10.1016/j.arth.2020.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。